EyeBio

EyeBio is a leading biotechnology research company focused on developing innovative therapies to protect, restore, and improve vision. EyeBio is dedicated to addressing sight-threatening eye diseases through cutting-edge biopharmaceutical solutions. With a commitment to advancing ophthalmology, EyeBio leverages its expertise in biotechnology to create a new generation of treatments.

EyeBio operates with a privately held structure, allowing for focused and agile development of its therapeutic pipeline. The company's commitment extends to patients, aiming to deliver solutions that significantly enhance their quality of life. EyeBio integrates advanced research and development to remain at the forefront of biotechnological advancements in ophthalmology.

With headquarters in London, GB, and a presence in New York, US, EyeBio is strategically positioned to drive innovation and accessibility in the field. The company specializes in biopharmaceuticals, ophthalmology, and biotechnology, ensuring a comprehensive approach to vision care. EyeBio is poised for continued growth and impact in the biotechnology sector.

To the manager of EyeBio, we invite you to create a customized and exclusive company showcase and product listing on our platform.